Heartflow, Inc. (HTFL)
About Heartflow, Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $176.0M
- Net income
- -$116.8M
- Total assets
- $359.5M
- Market cap
- $2.4B
- Gross margin
- 76.8%
- Operating margin
- -36.4%
- Net margin
- -66.3%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $176.0M
- Cost of revenue
- $40.8M
- Gross profit
- $135.2M
- Operating expenses
- $199.3M
- Operating income
- -$64.1M
- Income tax
- -$76.0K
- Net income
- -$116.8M
- EPS (basic)
- $-3.17
- EPS (diluted)
- $-3.17
Balance sheet
- Total assets
- $359.5M
- Current assets
- $220.2M
- Total liabilities
- $58.8M
- Current liabilities
- $42.4M
- Shareholders’ equity
- $300.6M
Cash flow
- Operating cash flow
- -$54.0M
- Investing cash flow
- -$238.6M
- Financing cash flow
- $286.0M
- Net cash flow
- -$6.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.4B
- EPS (diluted)
- $-3.17
- Shares outstanding
- 100.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 8, 2025
Heartflow, Inc. (HTFL) Stock Price
- Reported a net loss of $116.8M in FY2025.
- Gross margin of 76.8%, net margin -66.3%.
- Trading 40% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Heartflow, Inc..
Write a review
News about Heartflow, Inc.
News & sentiment via Polygon.io
Heartflow, Inc.: frequently asked questions
Is Heartflow, Inc. an American company?
Heartflow, Inc. is a US-based company headquartered in San Francisco, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Heartflow, Inc. headquartered?
Heartflow, Inc. is headquartered in San Francisco, California, United States.
Is Heartflow, Inc. publicly traded?
Yes — Heartflow, Inc. is a publicly traded company. Its stock trades under the ticker symbol HTFL on the NASDAQ.
What does Heartflow, Inc. do?
Heartflow, Inc. is an American Medical Devices company in the Health & Beauty sector.
